FOXP3 and neoplasm: NIR-PIT using an antibody–photoabsorber conjugate that targets CD25 selectively depletes the CD4+CD25+Foxp3+ Tregs infiltrating the tumor microenvironment and activates CD8+ T cells and natural killer (NK) cells, resulting in local anti-tumor immunity.